Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients.
暂无分享,去创建一个
J. McHutchison | E. Lawitz | A. Muir | L. Mcnair | M. Rodríguez-Torres | T. Kieffer | A. Khunvichai
暂无分享,去创建一个
J. McHutchison | E. Lawitz | A. Muir | L. Mcnair | M. Rodríguez-Torres | T. Kieffer | A. Khunvichai